Sebia acquires Zeus Scientific
Sebia, a global specialty diagnostic company providing solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, has acquired Zeus Scientific, an in vitro diagnostic (IVD) company based in New Jersey, U.S., specialized in autoimmune and infectious diseases techno- logies. Financial terms of the agreement are undisclosed.